Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MYRIAD GENETICS INCMYGN · Entity 5953 | Director | December 05, 2019 | December 06, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MYRIAD GENETICS INC
Report date December 05, 2019 · Filed December 06, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,790 |
Reported balance
After 2019-12-05 transaction · row 1
1 source rowRow 1 · 2019-12-05 · Grant · Acquired 11,687 · Balance 60,790 F1: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 05, 2019 Filed Dec 6, 2019 18:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 11,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001191248-19-000002 · edgardoc.xml · nonDerivative · entry 1 BEST LAWRENCE C · CIK 0001191248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,790 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| November 29, 2018 Filed Nov 30, 2018 17:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 9,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001191248-18-000002 · edgardoc.xml · nonDerivative · entry 1 BEST LAWRENCE C · CIK 0001191248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,103 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 00:28 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 7,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001191248-17-000002 · edgardoc.xml · nonDerivative · entry 1 BEST LAWRENCE C · CIK 0001191248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,743 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 00:06 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 15,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001191248-16-000004 · edgardoc.xml · nonDerivative · entry 1 BEST LAWRENCE C · CIK 0001191248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,524 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.